Middleton, Frank A.
https://orcid.org/0000-0002-3107-7188
Mayo Clinic
SUNY Upstate Medical University
Citations 2
PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Liao, Zhixiang , Locascio, Joseph J. , Lesniak, Kristen A., Roderick, Sarah S., Watt, Marla L., Eklund, Aron C. , Zhang‐James, Yanli , Kim, Peter D., Hauser, Michael A. , Grünblatt, Edna , Moran, Linda, Mandel, Silvia, Riederer, Peter , Miller, Renee M. , Federoff, Howard J. , Papapetropoulos, Spyridon , Youdim, Moussa B. H. , Cantuti‐Castelvetri, Ippolita, Young, Anne B., Vance, Jeffery M. , Hedreen, John C. , Beach, Thomas G. , Graeber, Manuel B., Middleton, Frank A. , Rochet, Jean‐Christophe , Scherzer, Clemens R. , Papapetropoulos, Spyros , Zheng, Bin , Wüllner, Ullrich , Davis, Richard L. , Adler, Charles H.
Science Translational Medicine | October 6, 2010 | Volume: 2 | Issue: 52 | Pages: No page available
Abnormal expression of genes for energy regulation in Parkinson’s disease patients identifies a master regulator as a possible therapeutic target for early intervention.
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
Fuchs, Julia , Kachergus, Jennifer M., Munz, Marita, Schüle, Birgitt , Langston, J. William, Middleton, Frank A. , Ross, Owen A. , Hulihan, Mary , Gasser, Thomas , Farrer, Matthew J. , Nilsson, Christer C. , Larsson, Elna‐Marie , Ross, Owen A
Neurology | January 25, 2007 | Volume: 68 | Issue: 12 | Pages: 916-922